Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
22/02/2010 | 22:00 | PR Newswire (US) | Dendreon Reports Fourth Quarter and 2009 Year End Financial Results | NASDAQ:DNDN | N^CURN |
11/02/2010 | 23:00 | PR Newswire (US) | Dendreon to Host Conference Call on February 22 to Announce Fourth Quarter and Full Year 2009 Results | NASDAQ:DNDN | |
03/02/2010 | 13:30 | PR Newswire (US) | Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference | NASDAQ:DNDN | |
05/01/2010 | 13:30 | PR Newswire (US) | Dendreon Announces Webcast Presentation at 28th Annual J.P. Morgan Healthcare Conference | NASDAQ:DNDN | |
12/12/2009 | 00:13 | PR Newswire (US) | Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering | NASDAQ:DNDN | |
11/12/2009 | 01:48 | PR Newswire (US) | Dendreon Announces Pricing of Common Stock Offering | NASDAQ:DNDN | |
10/12/2009 | 12:30 | PR Newswire (US) | Dendreon Appoints Hans Bishop as Chief Operating Officer | NASDAQ:DNDN | |
08/12/2009 | 23:09 | PR Newswire (US) | Dendreon Announces Proposed Public Offering of Common Stock | NASDAQ:DNDN | |
25/11/2009 | 13:30 | PR Newswire (US) | Dendreon Announces Webcast Presentations at Upcoming Investor Conferences | NASDAQ:DNDN | |
20/11/2009 | 14:30 | PR Newswire (US) | Dendreon Receives FDA Acknowledgement of Complete Response | NASDAQ:DNDN | |
11/11/2009 | 22:00 | PR Newswire (US) | Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization | NASDAQ:DNDN | |
02/11/2009 | 14:30 | PR Newswire (US) | Dendreon Completes Submission of Biologics License Application for PROVENGE | NASDAQ:DNDN | |
30/10/2009 | 12:30 | PR Newswire (US) | Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET | NASDAQ:DNDN | |
12/10/2009 | 18:59 | PR Newswire (US) | Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors | NASDAQ:DNDN | |
24/09/2009 | 18:51 | Dow Jones News | 2nd UPDATE: Dendreon Says Provenge Launch, Filing On Track | NASDAQ:DNDN | Dendreon Corp. |
24/09/2009 | 17:30 | Dow Jones News | UPDATE:Dendreon Sees Up To $2.5 Billion In Provenge Revenue If OK'd | NASDAQ:DNDN | Dendreon Corp. |
24/09/2009 | 15:54 | Dow Jones News | Dendreon Expects To File For Provenge Marketing Approval In Mid-Nov | NASDAQ:DNDN | Dendreon Corp. |
27/08/2009 | 13:30 | PR Newswire (US) | Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009 | NASDAQ:DNDN | |
11/08/2009 | 13:00 | PR Newswire (US) | Dendreon Reports Second Quarter 2009 Financial Results | NASDAQ:DNDN | |
30/07/2009 | 13:30 | PR Newswire (US) | Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET | NASDAQ:DNDN | |
14/05/2009 | 13:30 | PR Newswire (US) | Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacif | NASDAQ:DNDN | |
13/05/2009 | 17:08 | PR Newswire (US) | Dendreon Announces Closing of Common Stock Offering | NASDAQ:DNDN | |
08/05/2009 | 12:30 | PR Newswire (US) | Dendreon Announces Common Stock Offering | NASDAQ:DNDN | |
06/05/2009 | 13:30 | PR Newswire (US) | Dendreon Reports First Quarter 2009 Financial Results | NASDAQ:DNDN | |
30/04/2009 | 16:37 | PR Newswire (US) | TryPennyStocks.com Issues Hot Stocks On The Move Today: WFC, BRCD, DNDN, GS, FITB, MS, ETFC | NASDAQ:DNDN | |
29/04/2009 | 19:36 | Dow Jones News | Dendreon Drug Clears Difficult Hurdle, But Others Remain | NASDAQ:DNDN | Dendreon Corp. |
29/04/2009 | 15:20 | PR Newswire (US) | Stock Alerts on Industry Leaders: SYMC, DNDN, ALU, NFLX, VRTX, MHS; Issued by Beacon Equity | NASDAQ:DNDN | |
24/04/2009 | 21:25 | Dow Jones News | US EQUITIES WEEK AHEAD: 1Q Results, Chrysler Filing? | NASDAQ:DNDN | Dendreon Corp. |
24/04/2009 | 13:30 | PR Newswire (US) | Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting | NASDAQ:DNDN | |
22/04/2009 | 18:48 | PR Newswire (US) | TryPennyStocks.com Issues Technical Trade Alerts on Top Stocks In the Market Today: MS, ETFC, FITB, BRCD, DNDN, GS | NASDAQ:DNDN | |